# Conviction Capital

> Conviction Capital is a VC fund in London backing Artificial Intelligence and Medical. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 7
- Last investment: Jul 2025
- Lead investor: 14%
- Last updated: Aug 2026

Conviction Capital is a venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 4 | 57% |
| Medical | 2 | 29% |
| Analytics | 2 | 29% |
| Health Care | 2 | 29% |
| Legal | 1 | 14% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 43% |
| Seed | 2 | 29% |
| Pre-Seed | 1 | 14% |
| Series A | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 4 | 57% |
| Ireland | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OpenEvidence | OpenEvidence provides an artificial intelligence medical information platform that organizes and synthesizes peer-reviewed clinical research to help physicians access evidence-based insights for clinical decision support. Its products include an AI-powered medical search engine that quickly retrieves and cites relevant literature from majorjournals and tools like DeepConsult that generate comprehensive research syntheses for complex clinical questions. The platform also integrates features that support clinical documentation and evidence retrieval during patient encounters, aiming to streamline how healthcare professionals find and apply clinical evidence. OpenEvidence delivers responses grounded in sourced medical research and supports workflows that assist clinicians in evaluating and interpreting medical knowledge. | $210M | Series B | Jul 15, 2025 |  |
| Inventex | Inventex is a patent filling platform that help the businesses for filing application process without any hassle. | $2.4M | Pre-Seed | Apr 10, 2025 |  |
| Vultron | Vultron provides unparalleled AI for federal proposal development. | $4.9M | Seed | Oct 09, 2024 |  |
| Pika | Pika is a startup that is developing an AI-powered platform for editing and generating films from captions and still images. The company is revolutionizing the video creation and editing process through the integration of AI, offering a user-friendly and easily accessible tool for everyone. | $80M | Series B | Jun 05, 2024 |  |
| Orchid | Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California. | $12M | Seed | Dec 05, 2023 |  |
| Pika | Pika is a startup that is developing an AI-powered platform for editing and generating films from captions and still images. The company is revolutionizing the video creation and editing process through the integration of AI, offering a user-friendly and easily accessible tool for everyone. | $35M | Series A | Nov 28, 2023 |  |
| Profitero | Profitero is the eCommerce performance analytics platform of choice for leading brands around the world. With Profitero, brands can measure their digital shelf performance across 8,000+ retailer sites and mobile apps in 50 countries, gaining actionable insights to improve product content, search placement, ratings & reviews, availability,assortment and pricing. Profitero also allows brands to measure their Amazon sales & share and connect it to their digital shelf performance, so they can precisely identify the factors influencing sales. Many of the world’s leading brand manufacturers depend on Profitero’s granular and highly-accurate data to measure and improve their eCommerce performance. These include Bayer, Beiersdorf, iRobot, Edgewell, General Mills, Heineken, Kids II, MillerCoors and L’Oreal. | $20M | Series B | Apr 21, 2020 |  |

7 of 7 investments shown.

## Co-investors
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 8 deals together
- [Craft Ventures](https://shizune.co/investors/profile/craft-ventures) — VC Fund, 4 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 2 deals together
- [Greycroft](https://shizune.co/investors/profile/greycroft) — VC Fund, 2 deals together
- [Kleiner Perkins](https://shizune.co/investors/profile/kleiner-perkins-caufield-byers) — VC Fund, 2 deals together
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Conviction Capital invest in?

Conviction Capital invests primarily in Artificial Intelligence, Medical and Analytics startups, most often at Series B and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Conviction Capital last invest?

The most recent investment recorded for Conviction Capital closed in Jul 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co